Recent trends in the epidemiology of alcoholic liver disease
Ashwani K. Singal, Bhupinderjit S. Anand – 24 April 2013 – Watch a video presentation of this article
Reply
D. Alan Herbst, K. Rajender Reddy – 24 April 2013 – Watch a video presentation of this article
Histopathology of alcoholic liver disease
Neil D. Theise – 24 April 2013 – Watch a video presentation of this article
Natural history and factors influencing the course of alcohol‐related liver disease
Stuart Kendrick, Chris Day – 24 April 2013 – Watch a video presentation of this article
Natural history and factors influencing the course of alcohol‐related liver disease
Stuart Kendrick, Chris Day – 24 April 2013 – Watch a video presentation of this article
Cracking the ENCODE: From transcription to therapeutics
Gautam Mehta, Rajiv Jalan, Rajeshwar P Mookerjee – 22 April 2013
Therapeutic potential of interleukin 1 inhibitors in the treatment of alcoholic liver disease
Stephanie Mathews, Bin Gao – 22 April 2013
Analyzing risk factors for intrahepatic cholangiocarcinoma
Tetsuji Fujita – 22 April 2013
In Memoriam: David Hull, M.D.
Angel E. Alsina, John McNab – 13 April 2013
Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: An analysis of cutoff values
Sarah Raevens, Isabelle Colle, Koen Reyntjens, Anja Geerts, Frederik Berrevoet, Xavier Rogiers, Roberto I. Troisi, Hans Vlierberghe, Michel Pauw – 13 April 2013 – Portopulmonary hypertension (POPH), a complication of chronic liver disease, may be a contraindication to liver transplantation (LT) because of the elevated risk of peritransplant and posttransplant morbidity and mortality. Because POPH is frequently asymptomatic, screening with echocardiography is recommended. The only reliable technique, however, for diagnosing POPH is right heart catheterization (RHC).